Barberry

Berberis vulgaris · the bark, and the yellow alkaloid it is known for

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

A spiny European shrub with vivid yellow inner bark, barberry is best known for the alkaloid berberine. Interest in the plant is both historical and scientific, and its safety and regulatory status are under active review.

This article explains what barberry is, the chemistry of its key alkaloids, what research has focused on (reported as evidence), and the current regulatory and safety picture. It states WellsparQ’s use of barberry in our formulas and makes no health claims.

Ingredient Snapshot

What it is

A spiny European shrub whose inner bark and root contain yellow alkaloids.

Where from

Berberis vulgaris — stem and root bark.

Known for

Associated with the alkaloid berberine and related protoberberine compounds.

Barberry is the least familiar name in the formulas it belongs to — a spiny European shrub whose inner bark and root run a vivid yellow. That colour is the giveaway: it comes from berberine, an alkaloid the plant is closely associated with. Barberry has a long place in traditional herbalism, and it is currently the subject of active regulatory attention. This page sets out the botany and the chemistry plainly, reports the evidence and the regulatory picture as they stand, and makes no health claim.

The plant

Berberis vulgaris — European or common barberry — is a thorny deciduous shrub bearing clusters of small, tart red berries. The parts used in herbal preparations are chiefly the stem bark and root bark, which is where its characteristic alkaloids concentrate ^¹. Historically, in European and North American herbal traditions, the bark was used in various ways over a span of centuries ^¹. That is heritage, recorded here as cultural history rather than as evidence of any effect.

The chemistry: berberine and its relatives

The plant's signature is berberine, a quaternary isoquinoline (protoberberine) alkaloid and a bright yellow pigment. It rarely travels alone: barberry bark also contains related protoberberine alkaloids such as palmatine, jatrorrhizine and columbamine, among others ^¹². Berberine is the most studied of the group, and much of the published research on barberry is really research on berberine ^¹.

This is factual phytochemistry. Describing what a plant contains is not a health claim, and nothing in this section should be read as one.

What the research has examined — reported as evidence

Berberine has been studied a great deal, principally for lipid and glucose-related outcomes, in numerous randomised trials and reviews ^¹. It is important to be precise about what that means here. Those studies examine berberine, often as an isolated compound at defined doses; they are reported in the literature as research findings, with their own limitations. They are not a WellsparQ promise, and under UK/EU rules barberry and berberine carry no authorised health claim. We report that a body of research exists; we do not translate it into a benefit.

An important, current safety picture

Barberry deserves an unusually careful safety section, because the regulatory position is moving.

Following an assessment by France's food-safety agency ANSES, the European Commission asked EFSA to assess the safety of plant preparations containing berberine. EFSA's expert panel — with the draft also reviewed by the UK's Committee on Toxicity (COT) — assessed a list of berberine-containing plants that explicitly includes Berberis vulgaris (root, bark) ^³. The draft opinion, out for consultation in 2026, reached a striking overall conclusion: on the available data, a safe intake for humans could not be established for any of the plant preparations assessed ^³.

The panel's stated reasons include ^³:

• Evidence of berberine genotoxicity in vitro (gene mutation and chromosomal damage), with in-vivo confirmation still lacking;
• Sparse toxicological data on Berberis vulgaris preparations specifically, beyond their berberine content;
• Reports that berberine-containing supplements may cause transient gastrointestinal symptoms (constipation, diarrhoea, nausea, abdominal pain);
• Potential for berberine to inhibit the drug-metabolising enzyme CYP3A4, indicating a real risk of interactions with medicines;
• Berberine's IARC Group 2B listing (based on rodent carcinogenicity studies).

ANSES separately advised against use of berberine supplements in pregnancy and breastfeeding, in people with liver or heart conditions, and alongside medicines, and extended caution to children and adolescents ^³. None of this is settled law yet — it is a draft opinion under consultation — but it is exactly the kind of reputable, current signal a responsible brand should surface rather than bury. Anyone pregnant, breastfeeding, taking medication, or with a health condition should speak to a GP or pharmacist before using a barberry-containing product.

How WellsparQ uses it

Source: WellsparQ Supplements Database. In both, barberry is one botanical among several — part of the formula's character rather than a headline. Barberry is plant-derived; these formulas are suitable for vegetarians and vegans, and kosher and halal approved.

Where it fits

Barberry is an old European bark with a modern research story attached to its yellow alkaloid — and, right now, an unusually live safety conversation. We name it, place it honestly among its companions, and point plainly to the current regulatory picture. Rooted in nature, backed by research — and, where the research is still unsettled, we say so.